For the first time, the ARVO Foundation for Eye Research (AFER) will support AMD and dry eye research projects with two new fellowships for investigators under age 45. Traditionally, AFER's awards programs have recognized researchers' accomplishments rather than funded their research. The...
GM’s product renaissance is set to continue well into 2012, with the launch of two new Cadillac models. The ATS will be a dedicated competitor to other entry-level, rear-drive luxury sport sedans. As of right now, the ATS’s launch is planned for the summer of 2012, with production planned at the...
RegenoCELL Therapeutics, Inc. (OTCBB: RCLL) , a leader in adult stem cell therapy, is pleased to announce it is planning to open another state of the art facility in Panama for patients to be treated for congestive heart failure and peripheral artery disease with its autologous stem cell...
Pharmalucence, Inc. has received FDA approval expanding the route of administration and use of its Sulfur Colloid Injection (SCI) to include location of lymph nodes in breast cancer patients. Sulfur Colloid Injection (SCI) is a radioactive tracer manufactured by Pharmalucence which labels lymph...
Pharmasset, Inc. (Nasdaq: VRUS) announced the final sustained virologic response (SVR) results from its phase 2b PROTON study with PSI-7977 dosed once daily in combination with peginterferon alfa 2a and ribavirin (Peg-IFN/RBV) in subjects with hepatitis C virus (HCV) genotype 2 or 3 who have...
Taiho Pharmaceutical Co., Ltd. (HQ: Tokyo, President: Toru Usami) announced on July 22 the results of a randomized, Phase II clinical trial for the novel oral nucleoside antitumor agent TAS-102 under development by the company for metastatic colorectal cancer, at the 9th Annual Meeting of the...
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the U.S. Food and Drug Administration (FDA) clearance and limited market release of the Epiducer™ lead delivery system for neurostimulation therapy. This first-of-its-kind system allows physicians to place...
Ready to find out Posh Spice Jr.'s official name? Following the birth of his and Victoria Beckham's daughter Sunday, David Beckham hit Facebook to share the name of his first...
OMNIlife science, Inc. (a subsidiary of Orthopaedic Synergy, Inc.) announced clearance of its Apex PS Knee by the United States Food and Drug Administration. The Apex Posterior Stabilized (PS) Knee is the latest addition to the Apex Knee product family. The new design was introduced into the...
Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE - News) ("Ampio" or the "Company"), a company that discovers and develops new uses for previously approved drugs and new molecular entities ("NMEs") today announced treatment of the first patient in the three-arm, placebo controlled, 60 patient Phase 1b...
Marshall Edwards, Inc. (Nasdaq: MSHL), an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced today the publication of results from pre-clinical studies of Triphendiol, a prodrug of the Company's lead drug candidate NV-143, that...
Ritter Pharmaceuticals, Inc. (Ritter), a pharmaceutical company with a focus on digestive diseases, announced today that clinical investigators have enrolled the first patient in its randomized, double-blind, placebo-controlled Phase 2 study of RP-G28 in patients with symptoms associated with...